[1]
B. Atla, R. N. Sarkar, and M. Rasaputra, “Clinicopathological and IHC study (estrogen receptors, progesterone receptor, HER2/NEU) in malignant ovarian tumors”, Int J Res Med Sci, vol. 4, no. 4, pp. 1068–1073, Dec. 2016.